OncLive: Dr. Ruben Mesa on new trials and agents in the myelofibrosis pipeline
February 18, 2020
Dr. Ruben Mesa discusses the progress being made in treating patients with myelofibrosis.
KENS 5: Why clinical trials about cancer are so important in San Antonio
February 12, 2020
UT Health San Antonio Mays Cancer Center currently has more than 180 clinical trials.
Texas Public Radio: Cancer is the leading cause of death for Hispanics in the U.S.
February 11, 2020
Amelie Ramirez, Dr.P.H., professor and chair of the Department of Population Health Sciences and director of the Institute for Health Promotion Research at UT Health San Antonio, and Kate Lathrop, M.D., assistant professor of hematology/oncology at UT Health San Antonio and a care provider in the breast cancer program at the Mays Cancer Center, were […]
Dr. Yang receives UT System award to support blood cancer research
February 7, 2020
Professor Feng-Chun Yang, M.D., Ph.D., has been awarded a $1 million UT System Faculty STARs award.
KSAT 12: Why Deep Inspiration Breath-Hold is the weapon to fight cancer
February 6, 2020
Deep Inspiration Breath-Hold radiation therapy is being offered to enhance the ability to treat cancer patients. This type of therapy is only being offered here in San Antonio at the Mays Cancer Center, home to UT Health San Antonio MD Anderson.
San Antonio Express-News: Ethnic groups are underrepresented in cancer drug development. San Antonio researchers are trying to change that.
January 30, 2020
Dr. Virginia Kaklamani, associate director of clinical research at UT Health San Antonio, and Dr. Chethan Ramamurthy, assistant professor of genitourinary medical oncology with UT Health San Antonio, were both interviewed by Lauren Caruba about the importance of clinical trials and which ones are critical to advancing the field.